GSE42296

Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthritis and Crohn's disease

Whole-study status Not suitable

Dataset does not meet the current suitability threshold.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Source: GEO
Assay: microarray
Organism: Homo sapiens
Whole-study samples: 78 samples
Specimen: Biofluid
Reported/interpreted study design: Unclear study design Design classification does not establish patient pairs.

Comparison type: Tumor vs normal
Contributors: Mesko B, Poliska S, Vancsa A, Szekanecz Z, Palatka K, Hollo Z, Horvath A, Steiner L, Zahuczky G, Podani J, Nagy L
Contact name: Bertalan Mesko
Submission date: 2012-11-14
Last update: 2018-07-26
Organization: University of Debrecen
Department: Department of Biochemistry and Molecular Biology
Public date: 2013-06-25
Experiment types: Expression profiling by array
Platforms: GPL6244 [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]
Series type: Series
SubSeries: Not available
BioProject: PRJNA179561

Summary

We used microarrays to identify markers predicting responder status in infliximab treatment in 19 rheumatoid arthritis and 20 Crohn's disease patients at week 0 and week 2 of treatment.

Overall design

Peripheral blood samples were obtained at week 0 and week 2 of inxliximab treatment and global gene expression profiling identified markers of responder status.

Source Evidence

4 sources

Source	Contribution	Status
GEO	Original dataset metadata, sample metadata, source links, and GEO data availability flags. Sample records 78 GSM samples	Primary source
recount3	Planned trusted source for processed count availability.	No match found
Expression Atlas	Planned source for curated expression experiment links.	No match found
PubMed	Primary GEO citations and related PubMed articles that mention this dataset. 2 linked publications 2 DOIs Primary publication Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease. Genome medicine, 2013 PubMed DOI Related publications Integrated Gene Expression Profiling Analysis Reveals Probable Molecular Mechanism and Candidate Biomarker in Anti-TNFα Non-Response IBD Patients. Journal of inflammation research, 2020 PubMed DOI	Available

Metadata Quality Components

Persisted metadata quality

93 pts

Clarity: 93%
Weight: 100 pts

Sample source clarity: All samples have source metadata and clear GSE/GSM accessions. Group clarity: Only one side of the comparison is clearly grouped. Disease clarity: Disease or condition metadata normalized. Tissue clarity: Anatomical source metadata normalized. Treatment clarity: No unclear treatment split detected in the sample metadata. Replicate clarity: No pooled sample or technical replicate flags detected. Data availability clarity: Dataset-level processed or raw data availability is explicit.

Analysis Readiness

Not ready

55% DE readiness

Contrast completeness

10/25 pts

Only one side of the contrast is present; downstream DE needs both groups.

Minimum group size

0/20 pts

Minimum group size cannot be evaluated until a complete contrast exists.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

0/10 pts

Critical warnings must be resolved before downstream analysis.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

No complete case/control contrast is available.
Critical dataset warnings must be resolved.

Next Steps

Resolve critical warnings before downstream analysis.

Analysis Preparation Checklist

4/6 ready

Group labels reviewed

Blocked

No complete case/control grouping exists yet.

Review the sample grouping table and assign both case and control groups.

Minimum sample count met

Blocked

At least one group has fewer than 2 samples.

Choose a larger dataset or merge only scientifically valid groups.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Bioinformatician review required

Ask a bioinformatician to review grouping, count availability, exclusions, and design before DE.

Analysis readiness has blockers that must be resolved before DE.

Analysis preparation checklist contains blocked items.

No complete case/control or treatment/control contrast is available.

At least one comparison group has fewer than two samples.

Critical dataset warnings are present.

Assay context may require expert handling before DESeq2-style analysis.

Study design is model-system or unclear and should be reviewed before analysis.

Why This Is Ranked Here

Tumor vs normal

Not suitable Dataset does not meet the current suitability threshold.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

Assay differs from search intent Microarray Search intent expects bulk RNA-seq. Assay came from Normalization rules.
Disease context Crohn's disease, rheumatoid arthritis Disease context came from Normalization rules.
Likely case group Crohn's disease 78 samples
Likely control group No control group detected 0 samples

Intent Interpretation

Downgrade or exclusion reason Comparison: Unclear study design. Specimen: Biofluid. Comparison suitability: 0%. Derived from current-intent ranking reasons.

Ranking Facts

Supporting evidence

Interpreted disease metadata: Crohn's disease, Rheumatoid arthritis.
Processed data is available for downstream review.
External evidence: PubMed links 2 publications; 2 DOIs available: PMID 23809696, PMID 32104045.
Publication context: Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease.. Genome medicine, 2013. PMID 23809696. DOI 10.1186/gm463.
Publication context: Integrated Gene Expression Profiling Analysis Reveals Probable Molecular Mechanism and Candidate Biomarker in Anti-TNFα Non-Response IBD Patients.. Journal of inflammation research, 2020. PMID 32104045. DOI 10.2147/JIR.S236262.

Cautions

Comparison: Unclear study design. Specimen: Biofluid. Comparison suitability: 0%.
Downgraded for tissue search because it is a biofluid cohort.
Downgraded for tissue search because study design or specimen source is unclear.
Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
Blood, plasma, or serum cohort downgraded because this ranking targets tissue tumor-vs-normal comparisons.
Unclear study design downgraded for patient tissue tumor-vs-normal search intent.
Missing or unclear metadata. Unclear study design downgraded for patient tissue tumor-vs-normal search intent.
Microarray expression context downgraded below primary bulk RNA-seq for the default tissue ranking.
Overall score capped because comparison suitability is weak for the selected search intent.
Overall score capped because microarray cohorts should be compared separately from RNA-seq cohorts.
Missing or unclear metadata. Comparison - Unclear study design. Specimen - Biofluid. Comparison suitability: 0%.
Missing or unclear metadata. Downgraded for tissue search because study design or specimen source is unclear.
Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

No clear control group was detected from normalized metadata.
Microarray expression context was detected; compare separately from RNA-seq cohorts.
Multiple disease or phenotype arms were detected. The displayed grouping summarizes the full dataset; select the requested disease-specific contrast before analysis.
Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled.
Patient-tissue tumor-normal intent requires clear tumor-normal grouping.

Normalized Fields

395 fields

Field Value Source Derived by Confidence Evidence Reason

anatomical_source blood GSM1037296 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037297 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037298 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037299 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037300 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037301 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037302 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037303 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037304 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037305 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037306 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037307 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037308 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037309 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037310 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037311 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037312 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037313 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037314 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037315 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037316 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037317 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037318 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037319 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037320 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037321 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037322 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037323 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037324 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037325 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037326 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037327 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037328 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037329 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037330 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037331 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037332 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037333 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037334 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037335 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037336 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037337 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037338 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037339 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037340 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037341 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037342 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037343 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037344 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037345 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037346 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037347 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037348 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037349 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037350 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037351 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037352 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037353 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037354 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037355 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037356 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037357 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037358 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037359 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037360 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037361 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037362 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037363 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037364 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037365 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037366 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037367 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037368 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037369 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037370 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037371 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037372 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

anatomical_source blood GSM1037373 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence pbmc source_name: PBMC sample-anatomical-source-v1 sample-local anatomical source

assay_type microarray GSE42296 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence microarray dataset_accession: GSE42296 dataset_title: Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthrit... keyword match keyword match: microarray

cell_population peripheral blood mononuclear cells GSM1037296 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB14 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037297 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB17 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037298 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB18 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037299 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB22 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037300 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB27 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037301 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB28 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037302 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB33 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037303 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB34 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037304 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB37 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037305 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB40 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037306 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB39 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037307 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB44 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037308 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB42 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037309 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB41 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037310 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB26 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037311 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB23 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037312 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB13 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037313 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB08 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037314 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB03 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037315 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB01 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037316 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB16 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037317 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB19 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037318 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB21 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037319 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB24 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037320 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB29 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037321 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB30 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037322 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB35 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037323 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB36 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037324 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB38 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037325 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB43 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037326 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB46 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037327 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB49 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037328 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB47 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037329 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB45 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037330 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB31 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037331 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB25 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037332 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB15 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037333 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB11 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037334 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB05 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037335 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB02 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037336 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB07 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037337 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB101 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037338 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB103 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037339 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB104 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037340 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB31 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037341 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB41 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037342 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB63 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037343 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB72 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037344 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB83 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037345 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB90 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037346 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB93 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037347 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB97 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037348 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB98 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037349 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB28 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037350 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB35 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037351 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB42 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037352 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB53 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037353 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB56 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037354 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB60 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037355 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB17 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037356 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB105 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037357 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB106 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037358 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB107 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037359 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB43 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037360 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB50 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037361 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB66 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037362 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB75 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037363 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB87 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037364 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB94 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037365 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB96 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037366 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB100 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037367 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB102 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037368 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB38 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037369 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB44 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037370 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB52 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037371 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB59 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037372 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB62 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

cell_population peripheral blood mononuclear cells GSM1037373 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB68 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary cell population match: pbmc

disease Crohn's disease GSE42296 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease dataset_accession: GSE42296 dataset_title: Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthrit... controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease rheumatoid arthritis GSE42296 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis dataset_accession: GSE42296 dataset_title: Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthrit... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease Crohn's disease GSM1037296 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB14 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037297 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB17 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037298 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB18 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037299 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB22 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037300 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB27 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037301 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB28 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037302 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB33 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037303 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB34 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037304 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB37 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037305 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB40 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037306 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB39 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037307 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB44 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037308 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB42 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037309 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB41 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037310 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB26 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037311 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB23 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037312 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB13 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037313 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB08 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037314 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB03 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037315 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease Before treatment (week 0) IBDB01 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037316 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB16 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037317 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB19 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037318 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB21 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037319 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB24 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037320 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB29 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037321 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB30 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037322 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB35 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037323 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB36 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037324 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB38 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037325 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB43 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037326 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB46 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037327 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB49 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037328 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB47 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037329 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB45 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037330 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB31 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037331 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB25 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037332 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB15 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037333 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB11 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037334 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB05 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease Crohn's disease GSM1037335 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence Crohn's disease After treatment (week 2) IBDB02 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary disease match: Crohn's disease

disease rheumatoid arthritis GSM1037336 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB07 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037337 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB101 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037338 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB103 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037339 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB104 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037340 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB31 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037341 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB41 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037342 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB63 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037343 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB72 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037344 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB83 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037345 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB90 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037346 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB93 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037347 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB97 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037348 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB98 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037349 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB28 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037350 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB35 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037351 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB42 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037352 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB53 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037353 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB56 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037354 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis Before treatment (week 0) RAB60 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037355 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB17 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037356 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB105 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037357 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB106 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037358 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB107 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037359 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB43 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037360 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB50 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037361 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB66 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037362 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB75 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037363 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB87 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037364 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB94 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037365 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB96 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037366 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB100 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037367 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB102 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037368 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB38 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037369 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB44 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037370 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB52 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037371 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB59 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037372 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB62 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

disease rheumatoid arthritis GSM1037373 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence rheumatoid arthritis After treatment (week 2) RAB68 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary disease match: rheumatoid arthritis

organism Homo sapiens GSE42296 Runtime Siftome inference UNRESOLVED / UNREVIEWED high confidence homo sapiens dataset_accession: GSE42296 dataset_title: Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthrit... keyword match keyword match: homo sapiens

specimen_material PBMC preparation GSM1037296 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB14 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037297 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB17 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037298 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB18 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037299 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB22 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037300 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB27 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037301 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB28 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037302 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB33 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037303 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB34 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037304 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB37 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037305 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB40 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037306 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB39 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037307 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB44 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037308 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB42 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037309 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB41 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037310 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB26 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037311 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB23 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037312 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB13 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037313 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB08 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037314 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB03 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037315 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB01 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037316 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB16 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037317 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB19 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037318 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB21 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037319 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB24 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037320 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB29 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037321 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB30 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037322 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB35 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037323 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB36 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037324 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB38 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037325 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB43 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037326 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB46 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037327 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB49 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037328 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB47 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037329 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB45 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037330 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB31 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037331 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB25 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037332 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB15 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037333 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB11 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037334 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB05 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037335 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB02 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037336 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB07 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037337 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB101 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037338 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB103 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037339 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB104 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037340 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB31 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037341 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB41 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037342 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB63 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037343 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB72 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037344 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB83 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037345 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB90 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037346 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB93 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037347 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB97 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037348 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB98 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037349 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB28 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037350 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB35 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037351 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB42 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037352 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB53 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037353 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB56 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037354 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB60 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037355 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB17 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037356 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB105 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037357 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB106 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037358 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB107 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037359 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB43 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037360 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB50 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037361 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB66 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037362 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB75 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037363 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB87 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037364 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB94 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037365 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB96 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037366 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB100 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037367 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB102 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037368 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB38 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037369 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB44 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037370 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB52 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037371 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB59 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037372 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB62 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

specimen_material PBMC preparation GSM1037373 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB68 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary specimen material match: pbmc

tissue blood GSE42296 Runtime Siftome inference UNRESOLVED / UNREVIEWED low confidence blood dataset_accession: GSE42296 dataset_title: Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthrit... controlled vocabulary controlled vocabulary tissue match: blood

tissue blood GSM1037296 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB14 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037297 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB17 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037298 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB18 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037299 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB22 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037300 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB27 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037301 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB28 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037302 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB33 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037303 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB34 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037304 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB37 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037305 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB40 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037306 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB39 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037307 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB44 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037308 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB42 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037309 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB41 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037310 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB26 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037311 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB23 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037312 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB13 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037313 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB08 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037314 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB03 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037315 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) IBDB01 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037316 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB16 PBMC cell type: PBMC; subject: Patient 1; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037317 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB19 PBMC cell type: PBMC; subject: Patient 2; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037318 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB21 PBMC cell type: PBMC; subject: Patient 3; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037319 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB24 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037320 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB29 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037321 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB30 PBMC cell type: PBMC; subject: Patient 6; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037322 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB35 PBMC cell type: PBMC; subject: Patient 7; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037323 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB36 PBMC cell type: PBMC; subject: Patient 8; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037324 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB38 PBMC cell type: PBMC; subject: Patient 9; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037325 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB43 PBMC cell type: PBMC; subject: Patient 10; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037326 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB46 PBMC cell type: PBMC; subject: Patient 11; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037327 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB49 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037328 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB47 PBMC cell type: PBMC; subject: Patient 13; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037329 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB45 PBMC cell type: PBMC; subject: Patient 14; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037330 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB31 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037331 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB25 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037332 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB15 PBMC cell type: PBMC; subject: Patient 17; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037333 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB11 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037334 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB05 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037335 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) IBDB02 PBMC cell type: PBMC; subject: Patient 20; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Crohn's disease controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037336 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB07 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037337 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB101 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037338 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB103 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037339 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB104 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037340 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB31 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037341 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB41 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037342 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB63 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037343 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB72 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037344 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB83 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arth... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037345 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB90 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037346 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB93 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037347 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB97 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037348 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB98 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid art... controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037349 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB28 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037350 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB35 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037351 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB42 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037352 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB53 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037353 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB56 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037354 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc Before treatment (week 0) RAB60 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: Before treatment; time: week 0; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037355 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB17 PBMC cell type: PBMC; subject: Patient 1; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037356 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB105 PBMC cell type: PBMC; subject: Patient 2; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037357 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB106 PBMC cell type: PBMC; subject: Patient 3; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037358 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB107 PBMC cell type: PBMC; subject: Patient 4; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037359 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB43 PBMC cell type: PBMC; subject: Patient 5; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037360 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB50 PBMC cell type: PBMC; subject: Patient 6; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037361 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB66 PBMC cell type: PBMC; subject: Patient 7; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037362 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB75 PBMC cell type: PBMC; subject: Patient 8; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037363 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB87 PBMC cell type: PBMC; subject: Patient 9; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037364 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB94 PBMC cell type: PBMC; subject: Patient 10; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037365 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB96 PBMC cell type: PBMC; subject: Patient 11; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037366 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB100 PBMC cell type: PBMC; subject: Patient 12; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037367 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB102 PBMC cell type: PBMC; subject: Patient 13; response: NR - non-responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037368 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB38 PBMC cell type: PBMC; subject: Patient 14; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037369 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB44 PBMC cell type: PBMC; subject: Patient 15; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037370 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB52 PBMC cell type: PBMC; subject: Patient 16; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037371 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB59 PBMC cell type: PBMC; subject: Patient 17; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037372 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB62 PBMC cell type: PBMC; subject: Patient 18; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

tissue blood GSM1037373 Runtime Siftome inference UNRESOLVED / UNREVIEWED medium confidence pbmc After treatment (week 2) RAB68 PBMC cell type: PBMC; subject: Patient 19; response: R - responder; treatment: infliximab; time: week 2; disease state: Rheumatoid arthritis controlled vocabulary controlled vocabulary tissue match: pbmc

Sample Group Preview

showing 50 of 78 preview rows Show Hide

Study totals: Case 78 | Control 0 | Unassigned 0 | Excluded 0 | Ambiguous 0 showing 50 of 78 preview rows

Group	Role	Accession	Title	Source / characteristics	Reason
Crohn's disease	Case	GSM1037296	Before treatment (week 0) IBDB14	PBMC Cell type: PBMC; Subject: Patient 1; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037297	Before treatment (week 0) IBDB17	PBMC Cell type: PBMC; Subject: Patient 2; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037298	Before treatment (week 0) IBDB18	PBMC Cell type: PBMC; Subject: Patient 3; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037299	Before treatment (week 0) IBDB22	PBMC Cell type: PBMC; Subject: Patient 4; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037300	Before treatment (week 0) IBDB27	PBMC Cell type: PBMC; Subject: Patient 5; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037301	Before treatment (week 0) IBDB28	PBMC Cell type: PBMC; Subject: Patient 6; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037302	Before treatment (week 0) IBDB33	PBMC Cell type: PBMC; Subject: Patient 7; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037303	Before treatment (week 0) IBDB34	PBMC Cell type: PBMC; Subject: Patient 8; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037304	Before treatment (week 0) IBDB37	PBMC Cell type: PBMC; Subject: Patient 9; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037305	Before treatment (week 0) IBDB40	PBMC Cell type: PBMC; Subject: Patient 10; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037306	Before treatment (week 0) IBDB39	PBMC Cell type: PBMC; Subject: Patient 11; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037307	Before treatment (week 0) IBDB44	PBMC Cell type: PBMC; Subject: Patient 12; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037308	Before treatment (week 0) IBDB42	PBMC Cell type: PBMC; Subject: Patient 13; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037309	Before treatment (week 0) IBDB41	PBMC Cell type: PBMC; Subject: Patient 14; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037310	Before treatment (week 0) IBDB26	PBMC Cell type: PBMC; Subject: Patient 15; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037311	Before treatment (week 0) IBDB23	PBMC Cell type: PBMC; Subject: Patient 16; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037312	Before treatment (week 0) IBDB13	PBMC Cell type: PBMC; Subject: Patient 17; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037313	Before treatment (week 0) IBDB08	PBMC Cell type: PBMC; Subject: Patient 18; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037314	Before treatment (week 0) IBDB03	PBMC Cell type: PBMC; Subject: Patient 19; Response: R - responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037315	Before treatment (week 0) IBDB01	PBMC Cell type: PBMC; Subject: Patient 20; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037316	After treatment (week 2) IBDB16	PBMC Cell type: PBMC; Subject: Patient 1; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037317	After treatment (week 2) IBDB19	PBMC Cell type: PBMC; Subject: Patient 2; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037318	After treatment (week 2) IBDB21	PBMC Cell type: PBMC; Subject: Patient 3; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037319	After treatment (week 2) IBDB24	PBMC Cell type: PBMC; Subject: Patient 4; Response: NR - non-responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037320	After treatment (week 2) IBDB29	PBMC Cell type: PBMC; Subject: Patient 5; Response: NR - non-responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037321	After treatment (week 2) IBDB30	PBMC Cell type: PBMC; Subject: Patient 6; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037322	After treatment (week 2) IBDB35	PBMC Cell type: PBMC; Subject: Patient 7; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037323	After treatment (week 2) IBDB36	PBMC Cell type: PBMC; Subject: Patient 8; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037324	After treatment (week 2) IBDB38	PBMC Cell type: PBMC; Subject: Patient 9; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037325	After treatment (week 2) IBDB43	PBMC Cell type: PBMC; Subject: Patient 10; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037326	After treatment (week 2) IBDB46	PBMC Cell type: PBMC; Subject: Patient 11; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037327	After treatment (week 2) IBDB49	PBMC Cell type: PBMC; Subject: Patient 12; Response: NR - non-responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037328	After treatment (week 2) IBDB47	PBMC Cell type: PBMC; Subject: Patient 13; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037329	After treatment (week 2) IBDB45	PBMC Cell type: PBMC; Subject: Patient 14; Response: NR - non-responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037330	After treatment (week 2) IBDB31	PBMC Cell type: PBMC; Subject: Patient 15; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037331	After treatment (week 2) IBDB25	PBMC Cell type: PBMC; Subject: Patient 16; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037332	After treatment (week 2) IBDB15	PBMC Cell type: PBMC; Subject: Patient 17; Response: NR - non-responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037333	After treatment (week 2) IBDB11	PBMC Cell type: PBMC; Subject: Patient 18; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037334	After treatment (week 2) IBDB05	PBMC Cell type: PBMC; Subject: Patient 19; Response: R - responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Crohn's disease	Case	GSM1037335	After treatment (week 2) IBDB02	PBMC Cell type: PBMC; Subject: Patient 20; Response: NR - non-responder; Treatment: Infliximab; Time: Week 2; Disease state: Crohn's disease	Case marker detected.
Rheumatoid arthritis	Case	GSM1037336	Before treatment (week 0) RAB07	PBMC Cell type: PBMC; Subject: Patient 1; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037337	Before treatment (week 0) RAB101	PBMC Cell type: PBMC; Subject: Patient 2; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037338	Before treatment (week 0) RAB103	PBMC Cell type: PBMC; Subject: Patient 3; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037339	Before treatment (week 0) RAB104	PBMC Cell type: PBMC; Subject: Patient 4; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037340	Before treatment (week 0) RAB31	PBMC Cell type: PBMC; Subject: Patient 5; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037341	Before treatment (week 0) RAB41	PBMC Cell type: PBMC; Subject: Patient 6; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037342	Before treatment (week 0) RAB63	PBMC Cell type: PBMC; Subject: Patient 7; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037343	Before treatment (week 0) RAB72	PBMC Cell type: PBMC; Subject: Patient 8; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037344	Before treatment (week 0) RAB83	PBMC Cell type: PBMC; Subject: Patient 9; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
Rheumatoid arthritis	Case	GSM1037345	Before treatment (week 0) RAB90	PBMC Cell type: PBMC; Subject: Patient 10; Response: NR - non-responder; Treatment: Before treatment; Time: Week 0; Disease state: Rheumatoid arthritis	Case marker detected.
28 additional case samples are hidden from this preview.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.

Summary

Overall design

Source Evidence

Primary publication

Related publications

Metadata Quality Components

Analysis Readiness

Blockers

Next Steps

Analysis Preparation Checklist

Bioinformatician Review

Why This Is Ranked Here

Applied Review Decisions

Derived Classifications

Intent Interpretation

Ranking Facts

Supporting evidence

Cautions

Dataset Warnings

Normalized Fields

Sample Group Preview

Use as Discovery Cohort